Skip to main content

and
  1. Article

    Cannabinoid Receptor 1 Positive Allosteric Modulators for Posttraumatic Stress Disorder

    Anantha Shekhar, Ganesh A Thakur in Neuropsychopharmacology (2018)

  2. Article

    Open Access

    Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery

    Chemotherapeutic treatment results in chronic pain in an estimated 30-40 percent of patients. Limited and often ineffective treatments make the need for new therapeutics an urgent one. We compared the effects ...

    Elizabeth J Rahn, Liting Deng, Ganesh A Thakur, Kiran Vemuri in Molecular Pain (2014)

  3. Article

    Open Access

    The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy

    Chemotherapeutic agents produce dose-limiting peripheral neuropathy through mechanisms that remain poorly understood. We previously showed that AM1710, a cannabilactone CB2 agonist, produces antinociception witho...

    Liting Deng, Josée Guindon, V Kiran Vemuri, Ganesh A Thakur in Molecular Pain (2012)

  4. Article

    Erratum: The Novel Cannabinoid CB1 Receptor Neutral Antagonist Am4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

    Correction to: Neuropsychopharmacology (2008) 33, 946–955; doi:10.1038/sj.npp.1301476; published online 20 June 2007 In this article, the names of two authors were misspelled. The correct names are as follows:...

    Kelly S Sink, Peter J McLaughlin, Jodi Anne T Wood, Cara Brown in Neuropsychopharmacology (2008)

  5. Article

    The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

    Drugs that interfere with cannabinoid CB1 transmission suppress various food-motivated behaviors, and it has been suggested that such drugs could be useful as appetite suppressants. Biochemical studies indicat...

    Kelly S Sink, Peter J McLaughlin, Jodi Anne T Wood, Cara Brown in Neuropsychopharmacology (2008)